Should a contrast‑enhanced CT be obtained for an unknown mass, and when is a non‑contrast CT indicated?

CT With or Without Contrast for Mass of Unknown Origin

For a mass of unknown origin, obtain CT with intravenous contrast as the primary imaging modality, reserving non-contrast CT only for specific scenarios where contrast is contraindicated or when evaluating for particular tissue characteristics like fat or calcification.

Primary Recommendation

The approach depends critically on the anatomic location and clinical context of the mass:

For Renal Masses

CT with AND without IV contrast is optimal for evaluating indeterminate renal masses 1. This dual-phase approach is essential because:

• Enhancement detection is the cornerstone of diagnosis: The presence or absence of enhancement (>10-20 HU increase) distinguishes benign cysts from solid masses requiring further evaluation 1
• Cystic masses require both phases: The Bosniak classification system depends on identifying enhancing nodules, walls, or septa within cystic masses—information only obtainable with pre- and post-contrast imaging 1
• Solid masses benefit from fat detection: Small amounts of fat (indicating benign angiomyolipoma) may be obscured on contrast-enhanced CT alone, necessitating thin-section unenhanced images 1

Exception: Non-contrast CT alone suffices if the mass measures <20 HU or >70 HU (definitively benign) or contains obvious macroscopic fat 1.

For Adrenal Masses

Start with non-contrast CT 2. This is the most cost-effective initial approach because:

• Attenuation measurement on non-contrast CT ≤10 HU indicates adenoma with high specificity 2, 3
• If non-contrast CT is indeterminate (>10 HU), proceed to delayed enhancement CT (15-30 minutes post-contrast), which achieves sensitivity >95% and specificity >97% for distinguishing adenomas from metastases 2
• Chemical shift MRI is an alternative if the mass is discovered on contrast-enhanced CT and further characterization is needed 2

For Neck Masses

CT with IV contrast (without initial non-contrast phase) is the standard 4. Key points:

• Contrast improves characterization of cystic versus solid lesions, maps lesion borders, and identifies small primary sites in the upper aerodigestive tract 4
• Avoid ordering "with and without" contrast—this doubles radiation dose with minimal added benefit 4
• Non-contrast CT should only precede contrast if there's specific concern for calcification or hemorrhage

For Soft-Tissue Masses

MRI with contrast is preferred over CT for characterization 5. However, if CT is used:

• CT is most valuable for assessing mineralization patterns and cortical bone involvement 5
• Some pre-contrast images may be needed to distinguish subtle calcification from enhancement 5
• CT with contrast is appropriate when MRI is contraindicated (pacemakers, large body habitus) 5

Critical Pitfalls to Avoid

1. Don't routinely order "with and without" contrast for most masses: This doubles radiation exposure without proportional diagnostic benefit except for renal masses 4

2. Pseudoenhancement in small renal masses: Masses ≤1.5 cm may appear to enhance on CT due to partial volume averaging, leading to false-positive results 1. Consider dual-energy CT or alternative imaging if available.

3. Timing matters for adrenal masses: Immediate post-contrast imaging is insufficient—delayed imaging (15-30 minutes) is required to assess washout characteristics 2

4. Contrast contraindications require alternative strategies:

   • Renal insufficiency: Consider contrast-enhanced ultrasound (CEUS) for renal masses—microbubbles are not nephrotoxic 6
   • Contrast allergy: Non-contrast CT provides limited but useful information; MRI without contrast may be superior due to inherent soft-tissue characterization 4

Algorithmic Approach

Step 1: Identify mass location and clinical context

Step 2: Apply location-specific protocol:

• Renal: CT without + with contrast (multiphase protocol)
• Adrenal: CT without contrast first → if indeterminate, add delayed enhancement
• Neck: CT with contrast only
• Soft tissue: MRI with contrast preferred; CT with contrast if MRI unavailable

Step 3: If contrast contraindicated:

• Renal masses: CEUS or non-contrast MRI
• Adrenal masses: Chemical shift MRI
• Neck masses: Non-contrast MRI (limited utility) or specialist examination
• Soft tissue: Non-contrast MRI

Step 4: Interpret based on enhancement patterns, attenuation values, and morphologic features specific to the organ system

This evidence-based approach maximizes diagnostic accuracy while minimizing unnecessary radiation exposure and contrast administration 1, 2, 4, 5.